UBS Group Lowers RXO (NYSE:RXO) Price Target to $15.00

RXO (NYSE:RXO) had its price target lowered by analysts at UBS Group from $17.00 to $15.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective would suggest a potential upside of 22.30% from the stock’s current price.

A number of other research firms have also weighed in on RXO. Susquehanna lowered their price objective on shares of RXO from $11.00 to $10.00 and set a “negative” rating on the stock in a research report on Friday. Stifel Nicolaus boosted their price target on shares of RXO from $14.00 to $17.00 and gave the stock a “hold” rating in a research note on Friday, October 10th. Barclays cut their price target on shares of RXO from $17.00 to $15.00 and set an “overweight” rating for the company in a report on Friday. Wall Street Zen raised RXO from a “sell” rating to a “hold” rating in a report on Saturday, August 9th. Finally, JPMorgan Chase & Co. increased their target price on RXO from $15.00 to $16.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, RXO has an average rating of “Hold” and an average target price of $16.85.

RXO Stock Performance

Shares of RXO stock traded down $1.29 during trading on Friday, reaching $12.27. The company’s stock had a trading volume of 1,396,788 shares, compared to its average volume of 1,715,964. The firm has a market cap of $2.01 billion, a PE ratio of -5.68, a P/E/G ratio of 11.09 and a beta of 1.67. The company has a 50-day moving average price of $16.78 and a two-hundred day moving average price of $16.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. RXO has a fifty-two week low of $12.16 and a fifty-two week high of $31.11.

RXO (NYSE:RXO) last announced its earnings results on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). RXO had a negative net margin of 5.45% and a positive return on equity of 1.18%. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.44 billion. During the same period in the previous year, the company posted $0.05 earnings per share. RXO’s quarterly revenue was up 34.6% on a year-over-year basis. On average, analysts forecast that RXO will post 0.31 EPS for the current year.

Institutional Investors Weigh In On RXO

Several institutional investors and hedge funds have recently made changes to their positions in RXO. AlphaQuest LLC purchased a new position in RXO during the 2nd quarter valued at about $29,000. Geneos Wealth Management Inc. acquired a new stake in shares of RXO in the first quarter valued at approximately $30,000. Larson Financial Group LLC increased its stake in shares of RXO by 1,990.2% during the 1st quarter. Larson Financial Group LLC now owns 1,714 shares of the company’s stock worth $33,000 after purchasing an additional 1,632 shares in the last quarter. CWM LLC raised its position in shares of RXO by 234.4% during the 1st quarter. CWM LLC now owns 1,876 shares of the company’s stock worth $36,000 after purchasing an additional 1,315 shares during the last quarter. Finally, Jones Financial Companies Lllp raised its position in shares of RXO by 27.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 3,298 shares of the company’s stock worth $49,000 after purchasing an additional 701 shares during the last quarter. 92.73% of the stock is currently owned by hedge funds and other institutional investors.

About RXO

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.